Compare JJSF & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JJSF | ATRC |
|---|---|---|
| Founded | 1971 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Foods | Medical/Dental Instruments |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.6B |
| IPO Year | N/A | 2005 |
| Metric | JJSF | ATRC |
|---|---|---|
| Price | $89.86 | $40.33 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 9 |
| Target Price | ★ $138.33 | $52.22 |
| AVG Volume (30 Days) | 263.7K | ★ 530.6K |
| Earning Date | 02-02-2026 | 02-11-2026 |
| Dividend Yield | ★ 3.53% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.36 | N/A |
| Revenue | ★ $1,583,233,000.00 | $518,304,999.00 |
| Revenue This Year | N/A | $16.90 |
| Revenue Next Year | $2.24 | $12.29 |
| P/E Ratio | $26.99 | ★ N/A |
| Revenue Growth | 0.54 | ★ 15.80 |
| 52 Week Low | $80.67 | $28.29 |
| 52 Week High | $159.28 | $43.11 |
| Indicator | JJSF | ATRC |
|---|---|---|
| Relative Strength Index (RSI) | 44.12 | 58.53 |
| Support Level | $89.30 | $40.11 |
| Resistance Level | $94.30 | $41.92 |
| Average True Range (ATR) | 2.03 | 1.23 |
| MACD | -0.47 | -0.14 |
| Stochastic Oscillator | 10.73 | 44.02 |
J&J Snack Foods Corp. manufactures snack foods and distributes frozen beverages, which it markets nationally to the foodservice and retail supermarket industries. The company's portfolio of frozen beverages, frozen novelties, and baked goods includes soft pretzels, frozen juice treats and desserts, stuffed sandwiches, churros, funnel cakes, cookies, and other snack foods and drinks. It operates through three segments: Food Service, which sells snacks, desserts, and baked goods at the point of sale; Retail Supermarkets, which sells frozen and prepackaged products to supermarkets; and Frozen Beverages, which sells frozen beverages under the ICEE, Slush Puppie, and Parrot Ice brands in the United States, Mexico, and Canada. The majority of revenue comes from the Food Service segment.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.